About
Founded in 2009 by Thierry Laugel, Kurma Partners has established itself as a prominent venture Capital firm in Europe, focusing on healthcare and BioTech sectors. With a strong network of partners and collaborations with leading European research centers, Kurma Partners aims to transform disruptive scientific discoveries into cutting edge medicines and medical devices. The firm is committed to creating hightech companies, supporting early stage enterprises, and contributing to Sustainable development through its proactive ESG and ethical policies. Kurma Partners has financed over 60 companies and founded more than 24 since its inception. Notable milestones include the closing of their various funds, such as Kurma Biofund I, II, and III, and the establishment of the Kurma Diagnostics funds.